Simple jQuery Dropdowns

Browsing by Author GlaxoSmithKline plc.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 9 to 20 of 20 < previous 
Issue DateTitleAuthor(s)
1-Jan-2015Performance of binaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjectsLyda Osorio; Nick Carter; Preetam Arthur; Germana Bancone; Sowmya Gopalan; Sandeep K. Gupta; Harald Noedl; Sanjay K. Kochar; Dhanpat K. Kochar; Srivicha Krudsood; Marcus V. Lacerda; Alejandro Llanos-Cuentas; Ronnatrai Rueangweerayut; Ramadurai Srinivasan; Moritz Treiber; Jörg J. Möhrle; Justin Green; Universidad del Valle, Cali; GlaxoSmithKline plc.; Sri Ramachandra Medical College &amp; Research Institute (Deemed University); Shoklo Malaria Research Unit; MV Hospital and Research Centre; Medizinische Universitat Wien; Sardar Patel Medical College; University of Rajasthan; Mahidol University; Fundacao de Medicina Tropical do Amazonas; Universidad Peruana Cayetano Heredia; Mae Sot General Hospital; Clinical Development
1-May-2018Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1Carlo Giaquinto; Muthuhadini Patience Mawela; Kulkanya Chokephaibulkit; Marinella Della Negra; Ismail Haroon Mitha; Jan Fourie; Annie Fang; Elna van der Ryst; Srinivas Rao Valluri; Manoli Vourvahis; Rebecca Yanhui Zhang-Roper; Charles Craig; Lynn McFadyen; Andrew Clark; Jayvant Heera; ViiV Healthcare; Pfizer Limited, UK; Instituto de Infectologia Emilio Ribas; GlaxoSmithKline plc.; Sefako Makgatho Health Sciences University (SMU); Faculty of Medicine, Siriraj Hospital, Mahidol University; Pfizer Inc.; Università degli Studi di Padova; Medical Centre; Lakeview Hospital
1-Dec-2019Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial dataAngela Devine; Ayodhia P. Pasaribu; Tedlla Teferi; Huong Thu Pham; Ghulam Rahim Awab; Febrina Contantia; Thuy Nhien Nguyen; Viet Thanh Ngo; Tinh Hien Tran; Asrat Hailu; Kim Gilchrist; Justin A. Green; Gavin Ckw Koh; Kamala Thriemer; Walter Rj Taylor; Nicholas Pj Day; Ric N. Price; Yoel Lubell; GlaxoSmithKline, USA; Addis Ababa University; Universitas Sumatera Utara; University of Oxford; Menzies School of Health Research; UCL; GlaxoSmithKline plc.; Mahidol University; Tanjung Leidong Health Center; Nangarhar University; Arba Minch Hospital
1-Dec-1999Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in ThailandDouglas S. Walsh; Sornchai Looareesuwan; Polrat Wilairatana; D. Gray Heppner; Douglas B. Tang; Thomas G. Brewer; Watcharee Chokejindachai; Parnpen Viriyavejakul; Dennis E. Kyle; Wilbur K. Milhous; Brian G. Schuster; John Horton; David J. Braitman; Ralf P. Brueckner; Mahidol University; Walter Reed Army Institute of Research; U.S. Army Medical Materiel Development Activity; GlaxoSmithKline plc.
1-Nov-2017A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malariaMark M. Fukuda; Srivicha Krudsood; Khadeeja Mohamed; Justin A. Green; Sukhuma Warrasak; Harald Noedl; Ataya Euswas; Mali Ittiverakul; Nillawan Buathong; Sabaithip Sriwichai; R. Scott Miller; Colin Ohrt; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; GlaxoSmithKline plc.; Walter Reed Army Institute of Research; Medizinische Universitat Wien; Bangkok Hospital Medical Center; Bill and Melinda Gates Foundation; Consortium for Health Action
1-Jun-2016Replication and characterization of association between ABO SNPs and red blood cell traits by meta-analysis in EuropeansStela McLachlan; Claudia Giambartolomei; Jon White; Pimphen Charoen; Andrew Wong; Chris Finan; Jorgen Engmann; Tina Shah; Micha Hersch; Clara Podmore; Alana Cavadino; Barbara J. Jefferis; Caroline E. Dale; Elina Hypponen; Richard W. Morris; Juan P. Casas; Meena Kumari; Yoav Ben-Shlomo; Tom R. Gaunt; Fotios Drenos; Claudia Langenberg; Diana Kuh; Mika Kivimaki; Rico Rueedi; Gerard Waeber; Aroon D. Hingorani; Jacqueline F. Price; Ann P. Walker; Jackie Cooper; Ian N. Day; Maneka De Silva; Frank Dudbridge; Ghazaleh Fatemifar; Victoria Garfield; Steve E. Humphries; Debbie A. Lawlor; Teri Louise Davies; Vincent Plagnol; Christine Power; Sonia Shah; Reecha Sofat; Daniel I. Swerdlow; Philippa J. Talmud; Peter Whincup; John C. Whittaker; Delilah Zabaneh; University of Edinburgh; Icahn School of Medicine at Mount Sinai; UCL; London School of Hygiene &amp; Tropical Medicine; Mahidol University; Universitat Lausanne Schweiz; Swiss Institute of Bioinformatics; University of Cambridge; Barts and The London School of Medicine and Dentistry; UCL Institute of Child Health; University of South Australia; South Australian Health and Medical Research Institute; University of Bristol; Institute for Social and Economic Research, University of Essex; Centre Hospitalier Universitaire Vaudois; University of London; GlaxoSmithKline plc.
29-Mar-2013Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: A workshop reportLorenz Von Seidlein; Sarah Auburn; Fe Espino; Dennis Shanks; Qin Cheng; James McCarthy; Kevin Baird; Catherine Moyes; Rosalind Howes; Didier Ménard; Germana Bancone; Ari Winasti-Satyahraha; Lasse S. Vestergaard; Justin Green; Gonzalo Domingo; Shunmay Yeung; Ric Price; Menzies School of Health Research; Gokila; Australian Army Malaria Institute; University of Queensland; Eijkman-Oxford Clinical Research Unit; University of Oxford; Institut Pasteur du Cambodge; Shoklo Malaria Research Unit; The World Health Organization Regional Office for the Western Pacific philippines; GlaxoSmithKline plc.; PATH; Mahidol University; Nuffield Department of Clinical Medicine
15-Feb-2014Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: An open-label, multicenter, single-arm, Phase II studyFrancisco M. Marty; Choy Y. Man; Charles Van Der Horst; Bruno Francois; Denis Garot; Rafael Máňez; Visanu Thamlikitkul; José A. Lorente; Francisco Álvarez-Lerma; David Brealey; Henry H. Zhao; Steve Weller; Phillip J. Yates; Amanda F. Peppercorn; Brigham and Women's Hospital; Dept. of Clinical Development; GlaxoSmithKline, USA; University of North Carolina School of Medicine; Hopital Dupuytren; Hopital Bretonneau; Hospital Universitari de Bellvitge; Parc de Salut Mar; Hospital Universitario de Getafe; Mahidol University; UCL; GlaxoSmithKline plc.
29-Jul-2016Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)J. Bousquet; J. Farrell; G. Crooks; P. Hellings; E. H. Bel; M. Bewick; N. H. Chavannes; J. Correia De Sousa; A. A. Cruz; T. Haahtela; G. Joos; N. Khaltaev; J. Malva; A. Muraro; M. Nogues; S. Palkonen; S. Pedersen; C. Robalo-Cordeiro; B. Samolinski; T. Strandberg; A. Valiulis; A. Yorgancioglu; T. Zuberbier; A. Bedbrook; W. Aberer; M. Adachi; A. Agusti; C. A. Akdis; M. Akdis; J. Ankri; A. Alonso; I. Annesi-Maesano; I. J. Ansotegui; J. M. Anto; S. Arnavielhe; H. Arshad; C. Bai; I. Baiardini; C. Bachert; A. K. Baigenzhin; C. Barbara; E. D. Bateman; B. Beghé; A. Ben Kheder; K. S. Bennoor; M. Benson; K. C. Bergmann; T. Bieber; C. Bindslev-Jensen; L. Bjermer; H. Blain; F. Blasi; A. L. Boner; M. Bonini; S. Bonini; S. Bosnic-Anticevitch; L. P. Boulet; R. Bourret; P. J. Bousquet; F. Braido; A. H. Briggs; C. E. Brightling; J. Brozek; R. Buhl; P. G. Burney; A. Bush; F. Caballero-Fonseca; D. Caimmi; M. A. Calderon; CHU Montpellier; MACVIA-LR; Vieillissement et Maladies Chroniques. Approches Epidemiologiques et de Sante Publique; Universite de Versailles Saint-Quentin-en-Yvelines; Department of Health; National Health Service; KU Leuven; European Academy of Allergy and Clinical Immunology; Academic Medical Centre, University of Amsterdam; European Respiratory Society; iQ4U Consultants Ltd; Leiden University Medical Center - LUMC; Global Alliance Against Chronic Respiratory Diseases (GARD); International Primary Care Respiratory Group; Universidade do Minho, Escola de Ciencias da Saude; Universidade Federal da Bahia; GARD Executive Committee; EIP on AHA Commitment for Action; Skin and Allergy Hospital; University Hospital of Ghent; Universidade de Coimbra, Faculdade de Medicina; AgeingatCoimbra Reference Site; Azienda Ospedaliera Di Padova; Caisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR); EFA European Federation of Allergy and Airways Diseases Patients' Associations; Syddansk Universitet; Centro Hospitalar e Universitario de Coimbra; Medical University of Warsaw; Helsingin Yliopisto; Oulun Yliopisto; European Union; Vilniaus universitetas; European Academy of Paediatrics (EAP/UEMS-SP); Celal Bayar Universitesi; Turkish Thoracic Society; Charité – Universitätsmedizin Berlin; Secretary General of the Global Allergy and Asthma European Network (GA2LEN); Medizinische Universitat Graz; International University of Health and Welfare; Universitat de Barcelona; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias; University of Zurich; Inserm; Clinica Quiron; Centre de Recerca en Epidemiologia Ambiental, Barcelona; Hospital del Mar; CIBER Epidemiologia Y Salud Publica; Universitat Pompeu Fabra Barcelona; Digi Health; David Hide Asthma and Allergy Research Centre; Chinese Medical Association; Ospedale Policlinico San Martino; EuroAsian Respiratory Society; Faculdade de Medicina, Universidade de Lisboa; University of Cape Town; Universita degli Studi di Modena e Reggio Emilia; Universite de Tunis El Manar, Hopital Abderrahmene Mami; National Institute of Diseases of the Chest and Hospital; Linköpings universitet; Universität Bonn; Odense Universitetshospital; Skånes universitetssjukhus; Centre Européen de Recherche sur le Mouvement Humain, Université de Montpellier; Università degli Studi di Milano; Università degli Studi di Verona; Università degli Studi di Roma La Sapienza; Università degli Studi della Campania Luigi Vanvitelli; The University of Sydney; Université Laval; University of Glasgow; University Hospitals of Leicester NHS Trust; University of Leicester; McMaster University, Faculty of Health Sciences; Johannes Gutenberg Universität Mainz; National Heart and Lung Institute; GlaxoSmithKline plc.; Medical Research Council; Royal Brompton Hospital; Centro Medico Docente La Trinidad; University of Liverpool; Universidade Federal de Minas Gerais; Région Languedoc Roussillon; Oslo University Hospital; Allergy &amp; Asthma Associates of Southern California; Regional Ministry of Equality; University of South Florida, Tampa; Universidad Simón Bolívar; Asma e Immunologia; Panepistimio Kritis; Capital Institute of Pediatrics; Tbilisi State Medical University; Pulmonolory Research Institute FMBA; Latvian Psychiatric Association; Nova Southeastern University; Imperial College London; Karolinska Institutet; Technical University of Munich; CHU Strasbourg; EUREGHA; University of Edinburgh; Universitatea de Medicina si Farmacie Iuliu Hatieganu din Cluj-Napoca; Kronikgune; Sorbonne Universite
1-Jan-2014Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): A multicentre, double-blind, randomised, phase 2b dose-selection studyAlejandro Llanos-Cuentas; Marcus V. Lacerda; Ronnatrai Rueangweerayut; Srivicha Krudsood; Sandeep K. Gupta; Sanjay K. Kochar; Preetam Arthur; Nuttagarn Chuenchom; Jörg J. Möhrle; Stephan Duparc; Cletus Ugwuegbulam; Jörg Peter Kleim; Nick Carter; Justin A. Green; Lynda Kellam; Universidad Peruana Cayetano Heredia; Fundacao de Medicina Tropical do Amazonas; Mae Sot General Hospital; Mahidol University; MV Hospital and Research Centre; Sardar Patel Medical College; Sri Ramachandra Medical College &amp; Research Institute (Deemed University); Medicines for Malaria Venture; GlaxoSmithKline plc.
18-Feb-2016Tafenoquine treatment of Plasmodium vivax malaria: Suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trialPamela L. St Jean; Zhengyu Xue; Nick Carter; Gavin C.K.W. Koh; Stephan Duparc; Maxine Taylor; Claire Beaumont; Alejandro Llanos-Cuentas; Ronnatrai Rueangweerayut; Srivicha Krudsood; Justin A. Green; Justin P. Rubio; PAREXEL International; GlaxoSmithKline plc.; Medicines for Malaria Venture; Universidad Peruana Cayetano Heredia; Mae Sot General Hospital; Mahidol University; University of Melbourne
17-Jan-2019Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malariaAlejandro Llanos-Cuentas; Marcus V.G. Lacerda; Tran T. Hien; Iván D. Vélez; Chayadol Namaik-Larp; Cindy S. Chu; Maria F. Villegas; Fernando Val; Wuelton M. Monteiro; Marcelo A.M. Brito; Mônica R.F. Costa; Raul Chuquiyauri; Martín Casapía; Chau H. Nguyen; Sandra Aruachan; Ratchadaporn Papwijitsil; François H. Nosten; Germana Bancone; Brian Angus; Stephan Duparc; Graham Craig; Victoria M. Rousell; Siôn W. Jones; Elizabeth Hardaker; Donna D. Clover; Lindsay Kendall; Khadeeja Mohamed; Gavin C.K.W. Koh; Viviana M. Wilches; John J. Breton; Justin A. Green; GlaxoSmithKline, USA; Universidad Peruana Cayetano Heredia; Universidad de Antioquia; University of Oxford; Fundacao Oswaldo Cruz; GlaxoSmithKline plc.; Mahidol University; Medicines for Malaria Venture; IMAT Onco-medica; Centro de Investigaciones Clínicas; Oxford University Clinical Research Unit